In vitro toxicity and mutagenicity of CoCrMo and Ti6Al wear particles

Toxicology

Volumn 190, Issue 3, 2003, Pages 145-154

  Katzer, A ^a   Hockertz, S ^b   Buchhorn, G H ^c   Loehr, J F ^a  

^a ENDO Klinik   (Germany)

^b Institut für Toxikologie   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Carcinogenicity; Endoprosthesis loosening; Endoprosthesis metallic wear particles; Mutagenicity; Toxicity

Indexed keywords

ALLOY; ALUMINUM DERIVATIVE; CHROMIUM DERIVATIVE; COBALT COMPLEX; DIMETHYL SULFOXIDE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MOLYBDENUM COMPLEX; TITANIUM DERIVATIVE; WATER;

AMES TEST; ANALYTIC METHOD; ANIMAL CELL; ARTICLE; BIOASSAY; CARCINOGENIC ACTIVITY; CELL STRAIN V 79; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELUTION; EXTRACTION; IN VITRO STUDY; MAMMAL CELL; MICROSOME; MUTAGENICITY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RISK ASSESSMENT; SALMONELLA; STANDARDIZATION; TOXICITY;

BACTERIA (MICROORGANISMS); CRICETINAE; CRICETULUS GRISEUS; MAMMALIA; SALMONELLA;

EID: 0043135051     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(03)00147-1     Document Type: Article

References (34)

1. Albores-Saavedra J., Vuitch F., Delgado R., Wiley E. Sinus histiocytosis of pelvic lymph nodes after hip replacement. A histiocytic proliferation induced by cobalt-chromium and titanium. Am. J. Pathol. 18:(1):1994;83-90.
2. American Society for Testing and Materials, 1987. Standard practice for direct contact cell culture evaluation of materials for medical devices. Designation: F 813-83, Annual book of ASTM standards, Philadelphia, PA, pp. 323-327.
3. Ames B.N., McCann J., Yamasaki E. Methods for detecting carcinogens and mutagens with salmonella/mammalian microsome mutagenicity test. Mutat. Res. 32:1975;347-364.
4. Bartolozzi A., Black J. Chromium concentrations in serum, blood clot and urine from patients following total hip arthroplasty. Biomaterials. 6:1985;2-8.
5. Betts F., Wright T., Salvati E.A., Boskey A., Bansal M. Cobalt-alloy metal debris in periarticular tissues from total hip revision arthroplasties. Metal content and associated histological findings. Clin. Orthop. 276:1992;75-82.
6. Black J. Does corrosion matter? JBJS. 70B:1988;517-520.
7. Brien W.W., Salvati E.A., Healy J.H., Bansal M., Ghelman B., Betts F. Osteogenic sarcoma arising in the area of a total hip replacement. JBJS. 72A:1990;1097-1099.
8. Brien W.W., Salvati E.A., Betts F., Morris D.M. Metal levels in cemented total hip arthroplasty. A comparison of well fixed and loose implants. Clin. Orthop. 276:1992;66-74.
9. Brodner W., Grohs J.G., Bitzan P., Meisinger V., Kovarik J., Kotz R. Serumcobalt- und serumchromspiegel bei zwei chronisch niereninsuffizienten mit hüfttotalendoprothese und metall-metall-gleitpaarung. Z. Orthop. 138:2000;425-429.
10. Buchert P.K., Vaughn B.K., Mallory T.H., Engh C.A., Bobyn J.D. Excessive metal release due to loosening and fretting of sintered particles on porous coated hip prostheses. JBJS. 68A:1986;606-609.
11. Buchhorn, G.H., Willert, H.G., Semlitsch, M., Schoen, S., Steinemann, S., Schmidt, M., 1992. Preparation, characterization, and animal testing for biocompatibility of metal particles of iron-, cobalt-, and titanium-based implant alloys. In: John, K.R.S. (Ed.), ASTM STP 1144-Particulate Debris from Medical Implants: Mechanisms of Formation and Biological Consequences. ASTM-Publ., Philadalphia, PA, USA; ISBN 0-8031, pp. 177-188.
12. Case C.P., Langkamer V.G., James C., Palmer M.R., Kemp A.J., Heap P.F., Solomon L. Widespread dissemination of metal debris from implants. JBJS. 76B:1994;701-712.
13. Gillespie W.J., Frampton C.M.A., Henderson R.J., Ryan P.M. The incidence of cancer following total hip replacement. JBJS. 70B:1988;539-542.
14. Hamblen D.L., Carter R.L. Sarcoma and joint replacement. JBJS. 66B:1984;625-627.
15. Heath J.C., Freeman M.A.R., Swanson S.A.V. Carcinogenic properties of wear particles from prostheses made in cobalt-chromium alloy. Lancet. 1:1971;564-566.
16. Jensen D. A quantitative test for mutagenicity in V79 hamster cells. Kilbey, et al. Handbook of Mutagenicity Procedures. 1984;Elsevier, Amsterdam.
17. Katzer A. Dissemination of wear particles after alloplastic replacement of the anterior cruciate ligament: a study based on animal trials. J. Orthopaed. Traumatol. 3:2002;7-25.
18. Katzer A., Behnke B., Grabski H., von Foerster G. Isolierte Femurschaftosteolysen bei festsitzenden zementierten Hüftgelenkstotalendoprothesen. Akt. Traumatol. 32:2002;76-81.
19. Langkamer V.G., Case C.P., Heap P., Taylor A., Collins C., Pearse M., Solomon L. Systemic distribution of wear debris after hip replacement. JBJS. 74B:1992;831-839.
20. Mathiesen E.B., Ahlbom A., Bermann G., Lindgren J.U. Total hip replacement and cancer. JBJS. 77B:1995;345-350.
21. McCann J., Choi E., Yamasaki E., Ames B.N. Detection of carcinogens in the salmonella microsome test: assay of 300 chemicals. Proc. Nat. Acad. Sci. USA. 72:1975;5135.
22. Michel R., Nolte M., Reich M., Löer F. Systemic effects of implanted prostheses made of cobalt chromium alloys. Arch. Orthop. Trauma Surg. 110:1991;61-74.
23. Norseth T. Kreftfremkallende metaller. Tidskr. Nor. Laegefor. 109:1989;1638-1641.
24. Penman H.G., Ring P.A. Osteosarcoma in association with total hip replacement. JBJS. 66B:1984;632-634.
25. Rae T. The haemolytic action of particulate metals (Cd,Cr,Co,Fe,Mo,Ni,Ta,Ti,Zn,Co-Cr alloy). J. Pathol. 125:1978;81-89.
26. Snow E.T. Metal carcinogenesis: mechanistic implications. Pharmacol. Therapeut. 53:1992;31-65.
27. Sunderman F.W. Recent advances in metal carcinogesis. Ann. Clin. Lab. Sci. 14:(2):1984;93-122.
28. Sunderman F.W., Hopfer S.M., Swift T., et al. Cobalt, chromium and nickel concentrations in body fluids of patients with porous coated knee or hip prostheses. J. Orthop. Res. 7:1989;307-315.
29. Swierenga S.H.H., Gilman J.P.W., McLean J.R. Cancer risk from inorganics. Cancer Metastasis Rev. 6:1987;113-154.
30. Visuri T., Koskenvuo M. Cancer risk after McKee-Farrar total hip replacement. Orthopedics. 14:1991;137-142.
31. Visuri T., Pulkkinen P., Turula K.B., Paavolainen P., Koskenvuo M. Life expectancy after hip arthroplasty. Case control study of 1018 cases of primary arthrosis. Acta Orthop. Scand. 65:1994;9-11.
32. Visuri T., Pukkala E., Paavolainen P., Pulkkinen P., Riska E.B. Cancer risk after metal on metal and polyethylene on metal total hip arthroplasty. Clin. Orthop. 329:1996;280-289.
33. Westendorf, J., 1986. Struktur-und Wirkungsbeziehungen der Genotoxizität von Anthracyclin-Antitumor-Antibiotika, Habilitationsschrift. Fachbereich Medizin (Universität Hamburg).
34. Williams G. Batteries of short term tests for carcinogen screening. Williams G., et al. The Predictive Value of Short Term Screening Tests in Carcinogenicity Evaluation. 1980;327 Elsevier Biomedical Press, North Holland.